The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Galcanezumab
Australian Public Assessment Report
Device/Product Name
Emgality
Active ingredients
Galcanezumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2018-00780-1-1
Submission Type
New biological entity
Decision
Approved